PTC Therapeutics
| Use attributes for filter ! | |
| Stock price | PTCT |
|---|---|
| Disclaimer | |
| Headquarters | South Plainfield |
| New Jersey | |
| United States | |
| CFO | Emily Hill |
| Chief scientific officer | Mark J. Pykett |
| Subsidiary | Agilis Biotherapeutics, LLC |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1046068 |
About PTC Therapeutics
PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs that regulate gene expression by targeting post-translational control mechanisms in orphan diseases.
